Establishment of a Multidimensional Prediction Model for the Natural Course of VHL Disease-related Renal Cell Carcinoma
Conditions: VHL Syndrome; Renal Cell Carcinoma Interventions: Genetic: Single cell sequencing, whole genome and metabolomic sequencing Sponsors: Peking University First Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 30, 2024 Category: Research Source Type: clinical trials
Concurrent Chemoradiotherapy Followed by PD-1 Inhibitor in Advanced Cervical Cancer
Conditions: Locally Advanced Cervical Carcinoma; Concurrent Chemoradiotherapy; Immunotherapy Interventions: Drug: Albumin-Bound Paclitaxel, cisplatin, Sintilimab Sponsors: RenJi Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 30, 2024 Category: Research Source Type: clinical trials
Neoadjuvant Lu-PSMA Radioligand Therapy and Ipilimumab in Men With Very High-risk Prostate Cancer
Conditions: Very High Risk Prostate Carcinoma Interventions: Radiation: [177Lu]Lu-PSMA-617; Drug: Ipilimumab Sponsors: University Hospital, Essen; Advanced Accelerator Applications; Bristol-Myers Squibb Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 29, 2024 Category: Research Source Type: clinical trials
Pretreatment With HCQ Before Radiotherapy and Chemotherapy in Advanced NPC Patients
Conditions: Nasopharyngeal Carcinoma Interventions: Drug: HCQ; Other: Placebo Sponsors: Affiliated Hospital of Nantong University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 29, 2024 Category: Research Source Type: clinical trials
Pancreatic Cancer Detection Consortium
Conditions: Pancreatic Cancer; Pancreatic Carcinoma; Pancreatic Adenocarcinoma; Pancreatic Ductal Adenocarcinoma; Pancreatic Neoplasms; Pancreatic Cancer Stage I; Pancreatic Cancer Stage; Pancreatic Cancer Resectable; Pancreatic Cancer Stage 0; Pancreatic Cancer Stage II; Pancreatic Cancer Stage III; Pancreatic Cancer, Adult; Pancreatic Cancer Non-resectable Interventions: Diagnostic Test: PANcreatic cancer Exosome Early detectiON (PANXEON) Sponsors: City of Hope Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 29, 2024 Category: Research Source Type: clinical trials
Phase II Study of Moderate-dose Hypofractionated RT Combined With Pembrolizumab for HCC With Diffuse Tumor Thrombosis
Conditions: Hepatocellular Carcinoma; Radiotherapy; Pembrolizumab; Tumor Thrombosis Interventions: Radiation: Moderate-dose Hypofractionated Intensity-modulated Radiotherapy; Drug: Pembrolizumab Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 29, 2024 Category: Research Source Type: clinical trials
Serplulimab Combined With Nab-paclitaxel and Cisplatin in Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma
Conditions: Esophageal Squamous Cell Carcinoma Interventions: Drug: Serplulimab Combined With Nab-paclitaxel and Cisplatin; Drug: nab-paclitaxel ，Cisplatin Sponsors: Yang Jianjun, PhD Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 29, 2024 Category: Research Source Type: clinical trials
Accuracy of 18F-rhPSMA-7.3 PET/ MRI for Prediction of Lymph Node Metastasis in Localized High-Risk Prostate Cancer
Conditions: Localized Prostate Carcinoma; Oligometastatic Prostate Carcinoma; Stage I Prostate Cancer AJCC v8; Stage II Prostate Cancer AJCC v8; Stage III Prostate Cancer AJCC v8; Stage IVA Prostate Cancer AJCC v8 Interventions: Procedure: Bilateral Pelvic Lymph Node Dissection; Procedure: Biospecimen Collection; Procedure: Bone Scan; Procedure: Computed Tomography; Other: Electronic Health Record Review; Other: Flotufolastat F-18 Gallium; Procedure: Laparoscopic Radical Prostatectomy with Robotics; Procedure: Magnetic Resonance Imaging; Procedure: Positron Emission Tomography Sponsors: Mayo Clinic Not yet recruiting (Sour...
Source: ClinicalTrials.gov - April 29, 2024 Category: Research Source Type: clinical trials
Pharmacokinetics, Biodistribution, Radiation Dose and Safety Study of 68Ga-NYM005 in Patients
Conditions: Clear Cell Renal Cell Carcinoma Metastatic Interventions: Drug: 68Ga-NYM005 injection Sponsors: Norroy Bioscience Co., LTD Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 29, 2024 Category: Research Source Type: clinical trials
Molecularly Targeted Theranostic Approach for the Detection and Treatment of Metastatic Carcinomas
Conditions: Metastatic Cancer Interventions: Drug: [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G. Sponsors: University of California, Davis; National Institutes of Health (NIH) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 29, 2024 Category: Research Source Type: clinical trials
EQQUAL-NM for the Promotion of Smoking Cessation in Sexual and Gender Minority Young Adults in New Mexico
Conditions: Cigarette Smoking-Related Carcinoma Interventions: Behavioral: Smartphone App-delivered Smoking Cessation Intervention; Behavioral: Smartphone App-delivered Smoking Cessation Intervention; Other: Health Promotion and Education; Other: Health Promotion and Education; Other: Biospecimen Collection; Other: Questionnaire Administration Sponsors: Fred Hutchinson Cancer Center; National Cancer Institute (NCI); National Cancer Institute Center to Reduce Cancer Health Disparities; New Mexico State University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2024 Category: Research Source Type: clinical trials
Registry of Patients Undergoing Cryoablation for Early Stage Breast Cancer
Conditions: Early Stage Breast Carcinoma Interventions: Other: Non-Interventional Study Sponsors: Jonsson Comprehensive Cancer Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2024 Category: Research Source Type: clinical trials
Neoadjuvant PD-1 Blockade for Elderly Esophageal Squamous Cell Carcinoma (BLESS)
Conditions: Esophageal Cancer Interventions: Drug: neoadjuvant anti-PD-1; Drug: neoadjuvant anti-PD-1 with LDRT Sponsors: Shanghai Chest Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2024 Category: Research Source Type: clinical trials
Raman Spectroscopy and Skin Cancer
Conditions: Skin Cancer; Basal Cell Carcinoma; Squamous Cell Carcinoma Interventions: Device: Raman Spectroscopy handheld probe (EmVision, FL, USA); Device: Raman Spectroscopy laser source (Hubner Photonics Inc, CA, USA) Sponsors: Renee Cattell Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 25, 2024 Category: Research Source Type: clinical trials
A Clinical Study of Anti-CD70 UCAR-T in Relapsed or Refractory Solid Tumors
Conditions: Metastatic Tumor; Advanced Solid Tumor; Renal Cell Carcinoma; Ovarian Cancer; Cervix Cancer; Head and Neck Squamous Cell Carcinoma; Nasopharyngeal Carcinoma Interventions: Drug: CHT101 Sponsors: Zhejiang University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 25, 2024 Category: Research Source Type: clinical trials
